Galaxy Diagnostics, Inc. is a medical laboratory located in Research Triangle Park, North Carolina. The company specializes in advanced diagnostic testing for emerging infectious diseases, particularly those caused by flea- and tick-borne pathogens in humans and animals. It is recognized for its expertise in detecting Bartonella infections, including cat scratch disease, and other vector-borne diseases like Lyme borreliosis.

The company employs innovative sample enrichment technologies and patented growth media to enhance the detection of slow-growing pathogens that are often missed by traditional testing methods. Galaxy Diagnostics offers a variety of diagnostic services, including the Bartonella ePCR™ test and the Lyme Borrelia Nanotrap Antigen Test, which improve the sensitivity and specificity of tests for these infections. The company collaborates with healthcare providers, veterinarians, and research institutions to advance scientific knowledge and provide education on zoonotic and vector-borne diseases. Key leadership includes Dr. Edward B. Breitschwerdt and Dr. Ricardo Maggi, who bring strong academic and research backgrounds to the company.